Amy Trombly - Dec 29, 2023 Form 4 Insider Report for Sonoma Pharmaceuticals, Inc. (SNOA)

Role
Chief Executive Officer
Signature
/s/ Amy Trombly
Stock symbol
SNOA
Transactions as of
Dec 29, 2023
Transactions value $
$0
Form type
4
Date filed
12/29/2023, 05:26 PM
Previous filing
Jul 3, 2023
Next filing
Jun 21, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNOA Stock option (right to buy) Award +60K +52.79% 174K Dec 29, 2023 Common Stock 60K $0.18 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest one third each on 12/29/2024, 12/29/2025 and 12/29/2026, or upon change of control or as provided by Ms. Trombly's employment agreement.
F2 The options were awarded and granted to Ms. Trombly for services performed as part of the Company's annual grant of stock options.